Table 1.
Paper | Country | Time period of breast cancer deaths | Cases (n) | Screening exposure | Crude Ors (95% CI) | ORs adjusted for self-selection bias |
---|---|---|---|---|---|---|
Allgood et al. [15] | UK | 1995-2004 | 284 | Ever/Never attendance before (pseudo) diagnosis | 0.35 (0.24-0.51) | 0.52 (0.32-0.84) |
Fielder et al. [16] | Wales | 1998-2001 | 419 | Ever/Never attendance before (pseudo) diagnosis | 0.62 (0.47-0.82) | 0.75 (0.49-1.14) |
Gabe et al. [17] | Iceland | 1990-2002 | 226 | Ever/Never attendance before (pseudo) diagnosis | 0.59 (0.41-0.84) | 0.65 (0.39-1.09) |
Paap et al. [18] | Netherlands | 2004-2005 | 118 | Screened at index invitation | 0.30 (0.14-0.63) | 0.24 (0.10-0.58) |
Puliti et al. [19] | Italy | 1988-2002 | 1750 | Ever/Never attendance before (pseudo) diagnosis | 0.46 (0.38-0.56) | 0.55 (0.36-0.85) |
Roder et al. [20] | Australia | 2002-2005 | 491 | Ever/Never attendance before (pseudo) diagnosis | 0.59 (0.47-0.74) | 0.70a |
Source: Paap et al., 2010 [11] modified.
aValues of confidence interval not reported in the paper.